10 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
The Catholic University of Korea
From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.
Mutabilis
Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).
Affinium Pharmaceuticals
Azetidine based transition state analogue inhibitors of N-ribosyl hydrolases and phosphorylases.
Industrial Research
Targeting plague virulence factors: a combined machine learning method and multiple conformational virtual screening for the discovery of Yersinia protein kinase A inhibitors.
The Rockefeller University
Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
University of California Irvine
Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties.
Astrazeneca